New Stem Cell Therapy To Help With Stubborn Wounds PDF Print E-mail
Friday, 26 August 2011 12:13
The skin is the largest organ in the body with amazing healing powers, but what if your wounds didn't heal?

That's the case for 6 million Americans suffering from chronic wounds that can take months, even years, to heal. Millions have no other choice besides amputation; but now, a new stem cell therapy is helping to change that.

Limited scleroderma or CREST syndrome, is a subtype of Scleroderma, a condition that means "hardened skin." Skin changes associated with CREST syndrome typically occur in the lower arms and legs and sometimes in the face and throat. CREST syndrome can also affect the digestive tract and can cause serious heart and lung disorders. There is no known cure for Scleroderma, but treatments focus on managing symptoms and preventing serious complications. Sometimes, patients with this syndrome have a difficult time healing.

Doctors at the University of Miami Miller School of Medicine are participating in a study that takes stem cells from a patient's own body and uses them to treat their stubborn wounds. Adult stem cells are becoming a more realistic option for treating wounds that are refusing to heal. Certain stem cells can be isolated from bone marrow and other tissues, such as adipose and skin tissue.

Rapid regeneration of skin can be achieved after the transplantation of these cells. Stem cells can be obtained not only from the outside of the skin but also from local skin. Cell therapy is the transplantation of allogeneic cells to restore viability and function of deficient tissues.

Some scholars believe that the plasticity of stem cells is a result of the cell fusion between adult stem cells and skin cells. Therefore, it is important to create an appropriate microenvironment, which will be the determining factor as to whether or not stem cells will survive and participate in regeneration and reparation of wounds.

Researchers are already planning the next trial to test the use of donor bone marrow stem cells on the chronic wounds of patients whose own stem cells are likely compromised.

To learn more about this research, contact head of Media Relations with the University of Miami Miller School of Medicine Omar Montejo at (305) 243-5654 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Source: McFadden, M. (2011), "Healing wounds with your own stem cells", Gray Television Interactive, WNDU.com

 
More articles :

» The Pain Perspective in Scleroderma

Systemic sclerosis (scleroderma) is a disease in which inflammatory and fibrotic changes result in overproduction and accumulation of and other extracellular matrix proteins, resulting in intimal vascular damage, fibrosis, and occasionally organ...

» Genetic Accelerator Linked To Most Severe Cases of Lupus

A "genetic accelerator" is responsible for the most severe cases of Lupus (), an autoimmune disease: the accelerator, called enhancer HS1.2, speeds up the activity of some critical genes of the immune system involved in the disease.A team of Italian...

» Second Systemic Sclerosis World Congress a Success

Great success for the second Systemic Sclerosis World Congress that was held in February at the Palacio de Congresos de Madrid.After the positive experience of 2010 in Florence, organised the second edition the congress, on behalf of World...

» The Secrets of An Ancient Chinese Remedy, Revealed

For roughly two thousand years, Chinese herbalists have treated malaria using a root extract, commonly known as Chang Shan, from a type of that grows in Tibet and Nepal. Recent studies suggest that , a compound derived from the extract’s bioactive...

» Biomarker Shows Promise In Scleroderma

A biomarker that can be used to screen patients for has shown promise in a proof of concept study. Researchers from St Vincent’s in Melbourne found (ADMA) levels had an acceptable high specificity and sensitivity for detecting the complication,...

» Lidocaine for Systemic Sclerosis: A Double-blind Randomized Clinical Trial

Systemic sclerosis (scleroderma; SSc) is an orphan disease with the highest case-specific mortality of any connective-tissue disease. Excessive deposit in affected tissues is a key for the disease's pathogenesis and comprises most of the clinical...